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Abstract
Zika virus (ZIKV) is a mosquito borne flavivirus, which was a neglected tropical pathogen
until it emerged and spread across the Pacific Area and the Americas, causing large human
outbreaks associated with fetal abnormalities and neurological disease in adults. The fac-
tors that contributed to the emergence, spread and change in pathogenesis of ZIKV are not
understood. We previously reported that ZIKV evades cellular antiviral responses by target-
ing STAT2 for degradation in human cells. In this study, we demonstrate that Stat2-/- mice
are highly susceptible to ZIKV infection, recapitulate virus spread to the central nervous sys-
tem (CNS), gonads and other visceral organs, and display neurological symptoms. Further,
we exploit this model to compare ZIKV pathogenesis caused by a panel of ZIKV strains of a
range of spatiotemporal history of isolation and representing African and Asian lineages.
We observed that African ZIKV strains induce short episodes of severe neurological symp-
toms followed by lethality. In comparison, Asian strains manifest prolonged signs of neuro-
nal malfunctions, occasionally causing death of the Stat2-/- mice. African ZIKV strains
induced higher levels of inflammatory cytokines and markers associated with cellular infiltra-
tion in the infected brain in mice, which may explain exacerbated pathogenesis in compari-
son to those of the Asian lineage. Interestingly, viral RNA levels in different organs did not
correlate with the pathogenicity of the different strains. Taken together, we have established
a new murine model that supports ZIKV infection and demonstrate its utility in highlighting
intrinsic differences in the inflammatory response induced by different ZIKV strains leading
to severity of disease. This study paves the way for the future interrogation of strain-specific
changes in the ZIKV genome and their contribution to viral pathogenesis.
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Author summary
Zika virus is the most recent viral pathogen to cause a global public health emergency. It is
distinct from other flaviviruses in its ability to cause transplacental infection, fetal abnor-
malities and vector independent transmission through body fluids in humans. Over the
last year, there has been rapid progress in the development of animal models, which can
be used to study ZIKV pathogenesis. In this study, we demonstrate for the first time that
Stat2-/- mice are highly susceptible to ZIKV infection and recapitulate aspects of ZIKV
pathogenesis and disease. We use this model to delineate whether strain specific differ-
ences in ZIKV pathogenesis exist, using diverse strains representing both African and
Asian lineages. We show that African strains in general are more virulent than Asian
strains and their pathogenicity associates closely with the degree of inflammatory immune
response in the CNS of infected mice, and does not necessarily correlate with viral RNA
levels. Thus, we establish Stat2-/- mice as new model to study ZIKV pathogenesis and use
it to characterize inherent differences in the virulence among ZIKV strains. More impor-
tantly, we also highlight a potential role of the host inflammatory immune response in
mediating differential pathogenesis among ZIKV strains.
Introduction
The genus Flavivirus of the family Flaviviridae includes important vector-borne human patho-
gens such as dengue (DENV), yellow fever (YFV), West Nile (WNV), Japanese encephalitis
(JEV), and tick-borne encephalitis viruses (TBEV). Many of these viruses are prevalent in the
equatorial region of the globe that harbors the arthropod vectors required for their transmis-
sion [1–3]. Zika virus (ZIKV) is a recently emerged member of the flaviviruses which has
caused large outbreaks in human populations over the last decade and was recognized as a
Public Health Emergency of International Concern (PHEIC) by the World Health Organiza-
tion (WHO) in February 2016. It is a mosquito borne, enveloped virus with a 10.7 kb positive
sense single stranded RNA genome. Like other flaviviruses, the ZIKV genome encodes a poly-
protein, which is post-translationally processed by cellular and viral proteases into three struc-
tural proteins (Capsid/C; pre-membrane/prM; Envelope/E) and seven non-structural proteins
(NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). The structural proteins protect the genome,
participate in virus entry into and exit from the host cell, and are primary targets of the host
antibody mediated immune response. Non-structural proteins are required for viral genome
transcription and replication, proteolytic processing of the polyprotein and inhibition of cellu-
lar innate immune response [1–3]. ZIKV was first isolated in 1947 from a febrile rhesus
macaque in the Ziika forest in Uganda, where it circulated between nonhuman primates and
sylvatic Aedes africanus mosquitoes [4]. Subsequently, it was sporadically diagnosed in Africa
and Southeast Asia as a cause of mild self-limiting febrile disease in humans. In 2007, it caused
the first large-scale outbreak in the Yap islands, where more than 7,000 individuals were esti-
mated to be infected [3]. In 2013, ZIKV appeared in French Polynesia, where it infected
approximately 28,000 individuals [1–3]. Here for the first time, ZIKV infections were found to
be associated with increased incidences of Guillain-Barre´ syndrome, a debilitating neuronal
disease in adults. Also for the first time, ZIKV presence was detected in body fluids other than
blood (including semen, saliva, urine), and risk of direct human-to-human transmission was
observed. In 2014, ZIKV appeared in Brazil and by late 2015 the virus had spread across South
and Central America, the Caribbean and the southern parts of the United States [1–3].
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Importantly, during spread of ZIKV pandemic in Brazil, infections during pregnancy were
linked to fetal malformations such as spontaneous abortion, stillbirth, hydrocephaly and
microcephaly, and placental insufficiency to miscarriage, now collectively known as congenital
Zika virus syndrome (CZVS) [5].
Phylogenetic analysis of ZIKV genomes reveals African and Asian as two distinct lineages.
It has been postulated that ZIKV originated in East Africa, spread to West Africa and Asia
nearly 50~100 years ago, before making its appearance in the Western hemisphere in 2014 [6,
7]. The molecular determinants of ZIKV evolution, spread and disease phenotype have not
been established yet. Since the 2015 ZIKV epidemic in Brazil, efforts have been put forth by
several research groups to develop new in vitro, ex vivo and in vivo models to study ZIKV
infection and pathogenesis [2, 8]. Studies on stem cell derived neural progenitor cells and
brain organoid models showed neurotropism and pathogenicity of ZIKV [9]. Ex vivo human
placental tissue models have shown transplacental infection of ZIKV, its preference for tropho-
blasts and sensitivity to type III IFN [10, 11]. In the last year there have been extensive efforts
to develop new animal models to study ZIKV pathogenesis [8]. At the time of the original
ZIKV isolation, Dick et al tested ZIKV infection in several animal species including mice, cot-
ton rats, guinea pigs and rhesus macaques, and showed that only neonatal mice were prone to
symptomatic ZIKV infections [4, 12]. Later, ZIKV infection and disease symptoms were dem-
onstrated in neonatal mice, rhesus macaque and chicken embryos [8, 13–17]. Similar to den-
gue viruses, ZIKV does not cause infection and disease in wild type adult mice. To overcome
this limitation, scientists have used immunocompromised, neonatal or special mouse strains
such as SJL strain to study ZIKV pathogenesis [13, 14, 17–19]. Although mice are significantly
different than humans, especially in their placental anatomy and gestation period, scientists
have demonstrated their utility in reproducing ZIKV pathogenesis consistent with that in
humans [20]. Mouse models have been used to demonstrate ZIKV ability to cause fetal abnor-
malities, deterioration of gonadal tissue and infection through sexual route [8, 13, 21–28].
Immunocompromised mouse models have been useful in recapitulating the neurotropic
nature of ZIKV infection and in demonstrating a critical role of IFN induction and signaling
for protection against ZIKV [14, 17, 18].
In an earlier report, we showed that ZIKV targets human STAT2 for degradation, thereby
reducing induction of IFN stimulated genes (ISGs) and subsequent antiviral responses in
human cells, but not in mouse cells [29]. These findings were corroborated by another study
which also concluded proteasomal targeting of STAT2 by ZIKV NS5 protein [30]. Following
up on these observations we now demonstrate that ZIKV challenge in Stat2-/- mice results in
ZIKV infection and spread to CNS, gonads and other vital organs, with manifestation of neu-
rological symptoms. Further we have used the Stat2-/- mouse model to compare the virulence
and pathogenesis of a panel of ZIKV strains representing different lineages and spatio-tempo-
ral isolation histories.
Results
Stat2-/- mice are susceptible to ZIKV infection and display several key
aspects of human ZIKV pathogenesis
To investigate whether elimination of STAT2 in mice was sufficient to render mice susceptible
to ZIKV infection, we challenged Stat2-/- C57BL/6 mice with Uganda ZIKV (strain MR-766,
1947). We used a subcutaneous route to mimic the natural route of infection and recorded
ZIKV replication and pathogenesis. Specifically we injected 1,000 plaque formation units
(PFU) of Uganda ZIKV in the footpad of 5–6 week old female Stat2-/- mice. To compare the
sensitivity of these mice to ZIKV with other previously used mouse strains, Ifnar1-/- and wild
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type (WT) C57BL/6 mice were also infected using the same protocol [17, 18]. We monitored
body weight loss and clinical signs of disease every day. The Stat2-/- mice started losing weight
3 days post infection, and became morbid, displayed limited movement and succumbed to
infection between day 6 to 7 (Fig 1a and 1b). In comparison, Ifnar1-/- mice showed a delayed
onset of disease (Fig 1a and 1b), experienced less weight loss than Stat2-/- mice, displayed a
wider range of neurological symptoms, and succumbed to ZIKV infection between day 7 to 8
post infection (Fig 1a, 1b and 1c). Our results are in line with an earlier report where Uganda
ZIKV (MR766) challenge (100 PFU, footpad) resulted in 80% lethality in 5 week old Ifnar1-/-
mice by day 14 [17]. WT mice were refractory to ZIKV infection and did not display any signs
of disease (Fig 1a, 1b and 1c). ZIKV RNA measurements on day 6 post infection in the brain,
ovary, spleen and liver of Stat2-/- and Ifnar1-/- mice showed the highest viral RNA levels in the
brain, followed by ovary, spleen and minimum levels in the liver (Fig 1d). Interestingly, despite
delayed lethality, the viral RNA levels in Ifnar1-/- mice were higher than Stat2-/- mice in all the
organs tested, except in the brain. In addition, we also evaluated viremia and viral RNA levels
in the brain and ovaries of Stat2-/- mice on days 2, 4 and 6 post infection (S1 Fig). We observed
that Uganda ZIKV reached maximum RNA levels in serum (up to 10^9 ZIKV RNA copies/ml)
as early as 2 days post infection and showed slightly reduced levels by day 6 (S1a Fig). In com-
parison ZIKV RNA kept on increasing in brain tissue from day 2 to day 6 post infection (S1b
Fig). In the ovaries ZIKV reached maximum copy numbers by day 4 (S1C Fig). These trends
of temporal changes in ZIKV RNA in different organs are similar to what has been reported in
Ifnar1-/- mice [17]. Taken together, Stat2-/- mice support ZIKV infection, with virus spread to
CNS, gonads, spleen and liver. In comparison Ifnar1-/- mice show a delayed onset of disease,
but higher viral RNA levels in most of the sample tissues. In addition to STAT2 independent
signaling of IFN through the type I IFN receptor, the Stat2-/- and Ifnar1-/- differ in their ability
to support type I and III IFN signaling [31], which may explain their differential susceptibility
to ZIKV induced disease.
Phylogenetic and amino acid variance analysis of ZIKV strains selected
for comparison
Phylogenetically, ZIKV can be divided into African and Asian lineages [6, 7]. The African line-
age viruses have caused sporadic human infections in the last century, resulting in mild, febrile
disease symptoms [7]. The Asian lineage has however emerged at a larger scale displaying vec-
tor-borne as well as human-to-human transmission, causing fetal abnormalities and neuronal
disease in humans [3]. The factors responsible for emergence and global spread of ZIKV and
change in the disease phenotype are not understood presently. Also the impact of genetic
changes among ZIKV strains on their pathogenicity has not been studied in detail. To better
understand this, we chose a panel of ZIKV strains representing a range of global spatio-tempo-
ral isolation. Specifically, we evaluated Uganda 1947 (StrainMR_766), Senegal 1984 (Strain
DAKAR 41519) [4, 29, 32], Malaysia 1966 (Strain P6-740), Cambodia 2010 (Strain FSS13025),
Puerto Rico 2015 (strain PRVABC59). We refer to these ZIKV strains by the geographical loca-
tion of their isolation i.e. Uganda, Senegal, Malaysia, Cambodia and Puerto Rico. This panel of
ZIKV strains contains ZIKV isolated from 1947 to 2015 from human, mosquito and nonhu-
man primate hosts and from different locations covering the footprints of the geographical
spread of ZIKV (S1 Table). Two of the strains, Uganda and Malaysia, are mouse passaged (S1
Table). A phylogenetic analysis of the complete genome of the selected strains along with other
ZIKV genomes reveals their position in the African or Asian lineages (Fig 2a). The list of Gen-
Bank accession numbers of the ZIKV strains used to construct the phylogenetic tree is pro-
vided in S2 Table. A detailed amino acid sequence comparison of these strains is shown in
Study of Zika virus pathogenesis and host inflammatory immune response in a novel murine model
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Fig 1. Stat2-/- mice support ZIKV infection and recapitulate ZIKV pathogenesis and disease. Five to six week old female WT, Stat2-/- and
Ifnar1-/- C57BL/6 mice (n = 5) were injected with 1,000 PFU of ZIKV strain MR766 by the subcutaneous route in the footpad. (A) Mice were weighed
daily and weights are expressed as percentage of body weight prior to infection. Results shown are the mean ± standard error of the mean (SEM).
Data are censored at 6 days after infection, as mice in the Stat2-/- group succumbed to infection. (B) In a parallel set of mice (n = 5) lethality was
monitored for 14 days. (C) Clinical signs of ZIKV infection were monitored every day in the group of animals used for survival analysis (n = 5). Clinical
signs are abbreviated as HB (hunched back, reduced motility), HL1 (one hind limb paralysis), HL2 (both hind limbs paralyzed), FL (one or both front
limbs paralyzed), Endpoint (loss of 25% of initial body weight or dead). The percentage of each group of mice displaying the indicated signs is
shown. (D) From the group of mice used to monitor body weight loss (n = 5, day 6 post infection), indicated organs were harvested and ZIKV RNA
levels were measured by qRT PCR as described in methods. Error bars represent mean ±standard deviation (SD). Y axis starts at the limit of
detection of the assay.
https://doi.org/10.1371/journal.ppat.1006258.g001
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S1 File. Comparison of the overall amino acid composition shows maximum amino acid dif-
ferences between the Uganda and the contemporary Puerto Rico strains (Fig 2b). Amino acid
differences among the strains are observed throughout the viral polyprotein (Fig 2c), with
some regions (such as the amino terminal region of the prM protein, the E, the NS2A and NS5
proteins) showing a higher accumulation of changes, especially between the African and Asian
lineages (Fig 2c).
African ZIKV strains display higher virulence than Asian strains in Stat2-/-
and Ifnar1-/- mice
Although there have been several studies showing the utility of different mouse models to
study ZIKV pathogenesis, a comprehensive comparative analysis of different ZIKV strains in
vivo has not been carried out [8]. To address this we set out to compare the pathogenicity of a
panel of five ZIKV strains representing African and Asian lineages in Stat2-/-, Ifnar1-/- and WT
mice. Specifically we injected 1,000 PFU of the indicated ZIKV strain into the footpad of male
mice of the indicated genotype and monitored them every day for morbidity and mortality.
Among the African lineage viruses, the Senegal strain caused similar body weight loss in both
Stat2-/- and Ifnar1-/- mice (Fig 3a). In comparison Uganda ZIKV caused more weight loss in
Stat2-/- mice than Ifnar1-/- mice (Fig 3a). In terms of mortality all Stat2-/- and Ifnar1-/- mice suc-
cumbed to African ZIKV infections between day 6 to 8, with Stat2-/- mice displaying slightly
higher early mortality as compared to Ifnar1-/- mice (Fig 3c and 3d). Among Asian lineage
viruses all strains caused body weight loss, with Stat2-/- mice showing an earlier onset of mor-
bidity when compared to Ifnar1-/- mice (Fig 3b). Interestingly when compared to African
strains, Asian strains displayed delayed onset of disease and less severe morbidity in both
Stat2-/- and Ifnar1-/- mice (Fig 3a and 3b). Only the Cambodia strain caused limited mortality
at 1,000 PFU in Stat2-/- (20% mortality) and Ifnar1-/- mice (30% mortality) (Fig 3c and 3d). All
other mice infected with Asian lineage ZIKV strains seemed to recover from disease and
regained their original body mass (Fig 3b). In the study by Helen M Lazear et al, French Poly-
nesia strain (H/PF/2013) caused 100% lethality in Ifnar1-/- mice by day 10 at dose of 100 PFUs,
which is different from our observations with Asian strains. It could’ve resulted due amino
acid differences between different Asian strains. However for African lineage Senegal strain
(Dakar 41519) they also observed 100% lethality in 4 week old Ifnar1-/- mice, which is consis-
tent with our findings. The WT mice did not show any clear symptoms of disease with either
Asian or African ZIKV strains. Taken together these data show inherent differences in mor-
bidity and lethality induced by African and Asian ZIKV strains in Stat2-/- and Ifnar1-/- mice.
ZIKV pathogenicity does not directly correlate with the level of viral
replication in mice
Next we examined clinical symptoms induced by different ZIKV strains in Stat2-/- mice and
measured ZIKV viral RNA levels in the serum, CNS and gonads. Clinical signs of ZIKV disease
started with reduced motility and hunched posture followed by partial or complete paralysis in
hind limbs, front limbs and lethality. In most cases mice suffering front limb paralysis suc-
cumbed to the disease the same or next day. We observed that African lineage strains induced
higher mortality and severe neurological symptoms in a short period as compared to Asian
lineage strains (Fig 4a). Although all animals infected with African lineage strains succumbed
to infection, the Senegal strain induced more severe neurological symptoms such as paralysis
in all limbs (Fig 4a). Among Asian lineage strains the Cambodia strain presented more severe
symptoms including front limb paralysis and lethality, followed by the Malaysia and Puerto
Rico strains (Fig 4b). The Puerto Rico strain was the least pathogenic among all strains and all
Study of Zika virus pathogenesis and host inflammatory immune response in a novel murine model
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Fig 2. Phylogenetic analysis and amino acid variance of selected ZIKV strains. (A) Neighbor joining phylogenetic tree showing the
position of the viral isolates used in this study (in red) in the global ZIKV diversity. (B) Percent amino acid Identity Matrix of the 5 strains used in
this study. (C) Graphic representation of the pairwise amino acid changes between the strains used in this study. Each vertical line represents
an amino acid difference between the two connected strains. The order of the strains is as in (A). For a detailed description of all the amino
acid differences please refer to S1 File.
https://doi.org/10.1371/journal.ppat.1006258.g002
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Fig 3. Comparison of weight loss and mortality induced by African and Asian ZIKV strains in mice. Five to six week old male WT, Stat2-/- and
Ifnar1-/- C57BL/6 mice (n = 5) were injected with 1,000 PFU of the indicated ZIKV strain by the subcutaneous route in the footpad. (A, B) Mice were
weighed daily and weights are expressed as percentage of body weight prior to infection. Results shown are the mean ± standard error of the mean
(SEM). (A) Data are censored at 6 days after infection, as some mice died. (C, D) In a parallel group, male mice (n = 5) of the indicated genotype were
infected with indicated ZIKV strains under similar conditions and data were combined with body weight loss group for survival analysis (total n = 10).
ZIKV strains are abbreviated as UG (Uganda), SN (Senegal), ML (Malaysia), CB (Cambodia) and PR (Puerto Rico).
https://doi.org/10.1371/journal.ppat.1006258.g003
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Fig 4. Comparison of neurological disease and viral RNA levels among African and Asian ZIKV strains after infection in Stat2-/- mice. (A, B)
Clinical signs of ZIKV infection were monitored every day in the group of animals used for survival analysis in Fig 3 (n = 5). Clinical signs are abbreviated
as HB (hunched back, reduced motility), HL1 (one hind limb paralysis), HL2 (both hind limbs paralyzed), FL (one or both front limbs paralyzed),
Endpoint (loss of 25% of initial body weight or dead). The percentage of each group of mice displaying the indicated signs is shown. (A) Data represent
clinical signs observed between day 3 to day 7 post infection for the Uganda strain and day 4 to day 8 post infection for the Senegal strain. (B) Data
represent clinical signs induced by Asian lineage strains between day 6 to day 10 post infection. (C, D, E). Five to six week old male Stat2-/- mice (n = 5)
were infected with indicated ZIKV as described in Fig 3. On day 6 post infection indicated organs were harvested and ZIKV RNA levels were measured
by qRT PCR as described in methods. Error bars represent mean ±standard deviation (SD). Y axis starts at the limit of detection of the assay.
https://doi.org/10.1371/journal.ppat.1006258.g004
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mice recovered from disease symptoms by day 10 (Fig 4b). Similar trends were observed in
Ifnar1-/- mice as well (S1 Fig). In general Asian lineage strains presented delayed onset but pro-
longed, although less severe, neurological symptoms (up to 4 days) as compared to African
strains. We also measured viral RNA levels in serum, brain and testes of mice infected with dif-
ferent ZIKV strains at day 6 post infection. Interestingly the Uganda strain showed orders of
magnitude higher viral RNA level compared to all other strains including Senegal (Fig 4b, 4c
and 4d), especially in brain tissue. Similarly, among Asian strains the Malaysia strain showed
elevated viral RNA compared to Cambodia and Puerto Rico ZIKV (Fig 4b, 4c and 4d). Both
Uganda and Malaysia strains are mouse passaged strains (S1 Table), which may explain their
higher replication compared to their lineage specific counterparts. In any case, these data
clearly show that pathogenicity manifested by different ZIKV strains is not in direct correla-
tion with the level of viral replication in mice.
Degree of ZIKV virulence correlates with levels of inflammatory cytokine
induction in mice
Earlier reports had shown that ZIKV infection in animal models is associated with the activa-
tion of immune responses, cellular infiltration, inflammation and neural damage in the CNS
[13, 15, 25]. To test if this may be the underlying cause of the difference in pathogenicity
between the African and Asian lineages of ZIKV, we measured markers associated with IFN
induction, expression of inflammatory cytokines and recruitment of immune effector cells in
the brain of Stat2-/- mice on day 6 post infection. For measuring cytokine and chemokine
induction, we measured both mRNA expression and protein levels by qRT-PCR and multiplex
ELISA, respectively. We observed higher levels of type I and type II IFNs and cytokine induc-
tion by African lineage strains as compared to the Asian lineage strains (Fig 5a, 5b, 5c and 5d).
Specifically, we observed enhanced levels of hallmark inflammatory cytokines such as IL6,
IP10, TNFα, IFNγ, as well as chemokines associated with T cell infiltration (CCL3, CCL4,
CCL5, and CXCL9) and cytolytic response (GZMB, IFNγ), monocyte/macrophage infiltration
(CCL2, CCL7), and neutrophil migration (CXCL1 and CXCL2). Additional cytokines with
known antiviral activity were also induced, such as IL-1b and IL15 [33, 34]. In general, these
cytokines were induced to a greater extent by the African strains than Asian strains (Fig 5a, 5b,
5c and 5d). Markers associated with infiltration of T cells (CD4, CD8, CCR5,CXCR3), mono-
cytes (CCR2,CCR5) and NK cells (CCR5) were also differentially upregulated, while microglial
activation appeared to be uniformly induced irrespective of the ZIKV strain as measured by
CX3CR1 expression (Fig 5b). Taken together induction of an exacerbated inflammatory
immune response in the CNS is a better indicator of ZIKV pathogenicity in mice than viral
RNA levels. To test whether gender of the mice affected ZIKV strain specific pathogenesis, we
repeated ZIKV challenge with Senegal, Cambodia and Puerto Rico strains in female Stat2-/-
mice as done before with male mice. We observed similar pattern of body weight loss, ZIKV
viral RNA and inflammatory cytokine levels in the mouse brain (S3a, S3b and S3c Fig) as seen
in male mice (Figs 3–5), thus differences in African and Asian ZIKV strain specific pathogene-
sis were independent of mouse gender.
Discussion
In November 2016 WHO declared that ZIKV is no longer a public health emergency, however
it remains a serious public health concern, especially in the light of recent studies showing fetal
microcephaly and other long-term cognitive disorders resulting from ZIKV infection [35].
From a scientific perspective, there is still an extensive knowledge gap on ZIKV evolution, biol-
ogy and pathogenesis. From the first isolation of ZIKV in 1947 until 2015, there were only
Study of Zika virus pathogenesis and host inflammatory immune response in a novel murine model
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Fig 5. Comparison of inflammatory immune response induced by African and Asian ZIKV strains in the CNS of Stat2-/- mice. (A, B, C) Brain
tissue homogenates were prepared from the group of male Stat2-/- mice used to measure ZIKV RNA (n = 5) (Fig 4C, 4D and 4E) and a control group
of age matched, mock infected male Stat2-/- mice (n = 5). Gene expression was measured by qRT PCR as described in the methods section. Fold
change of the gene expression over the mock was calculated and plotted on the graphs. Data are presented as mean ±standard deviation (SD) of
log 2 fold increase over mock controls. Genes are grouped into indicated functional categories. (D) In the same set of brain homogenates, indicated
cytokine and chemokine levels were measured by multiplex ELISA assay, as described in the methods section. Data are presented as mean of log 2
fold increase over mock controls.
https://doi.org/10.1371/journal.ppat.1006258.g005
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three studies which tested the virus’ pathogenic potential in animal models [12, 13, 36]. Since
then there have been several more which have utilized various mouse models to study different
aspect of ZIKV pathogenesis and revealed critical evidence of neuropathology and fetal abnor-
malities associated with ZIKV infection [8]. Mouse models remain an attractive option
because of their amenability for genetic manipulation and the availability of a vast repertoire
of mouse strains, which allows investigation of the role of specific host genetic loci in viral
pathogenesis. Using mouse strains deficient in various components of antiviral signaling,
researchers had shown a critical role of type I IFN signaling in preventing ZIKV infection in
mice [14, 17, 18]. Shannan L Rossi et al compared susceptibility of A129 (lack type I IFN
response) and AG129 (lack type I and II IFN response) mice to ZIKV challenge and found the
latter to be more prone to severe disease [19]. This highlighted the role of type I and II IFN
response against ZIKV. Later on irf3-/-irf5-/-irf7-/- triple knock out mice which are compro-
mised in type I, II and III IFN induction were shown to be more susceptible to ZIKV induced
disease as compared to Ifnar1-/- mice (lack type I IFN response) [17], which pointed to impor-
tance of type II and III IFN response against ZIKV. In our previous studies on the role of
ZIKV NS5 protein in antagonizing the antiviral host response, we found that, similar to
DENV, ZIKV targets STAT2 for degradation in human cells and not in mouse cells, although
probably through the involvement of different host co-factors [29]. This knowledge led us to
hypothesize that STAT2 could be critical for preventing ZIKV infection in animal models.
Indeed in our study, Stat2-/- mice were highly susceptible to ZIKV infection and disease. In
comparison Ifnar1-/- mice showed in general delayed disease symptoms and less body weight
loss due to ZIKV infection than Stat2-/- mice. While Ifnar1-/- mice lack type I IFN signaling,
Stat2-/- mice lack both type I and type III IFN signaling [31]. This may explains the difference
in their susceptibility to ZIKV induced disease and suggests a critical role of type III IFN in
mediating antiviral responses against ZIKV. This is in accordance with the findings of Bayer
et al [10] who showed protective role of type III IFN against ZIKV infection in human placen-
tal tissue. However, for the differences observed between Stat2-/- and Ifnar1-/- mice, we cannot
exclude the possible role of STAT2 independent, IFNAR1 dependent, type I IFN signaling.
Immunocompromised mouse models are useful options when WT mice are refractory to viral
infection. In our study Stat2-/- mice recapitulated ZIKV tissue tropism to CNS and gonads and
displayed neurological symptoms of various degrees, which are consistent with human disease.
It will be interesting to test ZIKV infection of Stat2-/- as well as Stat2-/+ heterozygous mice in
pregnancy models to see whether they can simulate the transplacental infection and neurotera-
togenic properties of ZIKV.
In vitro stem cell derived models have been very useful in confirming the neurotropic
nature and teratogenic potential of ZIKV [9, 37–39]. In recent studies of gene expression pro-
files induced by African and Asian ZIKV in neural progenitor cells, it was found that African
ZIKV induces higher levels of transcripts associated with inflammation and cell death which is
consistent with our findings in infected Stat2-/- mice [39, 40]. However an independent study
using human induced pluripotent stem cell (iPSC) derived brain organoids showed that
African and Asian lineage ZIKV strains display similar inhibitory effects on neuronal differen-
tiation and organoid development [37]. In our study, African and Asian strains display drasti-
cally different virulence in mice. We found that African strains tend to be more lethal, with
severe short episodes of neural malfunction, whereas Asian strains yield wider spectrum of
neurological symptoms which last for longer period and seldom result in mortality. Interest-
ingly the ZIKV RNA levels in CNS or other organs did not directly correlate with virulence.
Among African strains, Uganda ZIKV replicated to higher levels than the Senegal strain
although they manifested similar virulence. Similarly among Asian strains Malaysia replicated
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to slightly higher levels than the Cambodia strain, however Cambodia ZIKV displays more
severe disease as compared to Malaysia ZIKV. Both Uganda and Malaysia strains are mouse
passaged, which may explain higher replication levels as compared to their lineage specific
counterparts.
Consistent with earlier reports showing CNS inflammation in ZIKV infected neonatal mice
and Rhesus macaques [15, 25], infection of Stat2-/- mice with all ZIKV strains led to inflamma-
tory immune responses in the brain. Importantly, the differences in ZIKV strain-specific path-
ogenesis were found to be closely correlated with the level of induction of inflammatory
cytokines and possible recruitment of immune effector cells to the CNS of infected mice.
These findings highlight that disease severity induced by ZIKV infection is more likely a prod-
uct of the host response, rather than the level of viral replication, at least in immunocompro-
mised mouse models. We also observed that, other than Uganda, all ZIKV strains achieved
similar viral RNA levels in the mouse brain, however this led to variable induction of IFNα,
IFNβ, and IFNγ. This could have resulted from differences in the ability of ZIKV strains to
antagonize the induction of IFN. As these mice lacked STAT2, the NS5 mediated IFN antago-
nism through degradation of STAT2 does not account for these differences. For ZIKV and
other flaviviruses, IFN antagonism has also been attributed non-structural proteins other than
NS5 [30, 41]. It would be interesting to investigate whether amino acid changes in specific
viral proteins among different ZIKV strains result in differential IFN antagonism in mouse
and in human systems.
It is critical to understand the factors which facilitated sudden emergence and spread of
ZIKV, to take preventive measures in the future. It is likely that global warming, deforesta-
tion, increased prevalence of Aedes sp. mosquitoes, increased global transportation of ZIKV
infected individuals and immunological naivety of human populations in new areas may
have facilitated these events. However it is also plausible that during the course of its evolu-
tion ZIKV acquired changes in its genome [6] that may have driven its global spread. In
humans, ZIKV induced neurological symptoms and fetal abnormalities have been only
reported in the case of Asian strains [3]. Interestingly, in our study Asian strains displayed
prolonged neurological malfunction in mice as compared to the African strains. However it
is important to acknowledge that human sero-epidemiological data of African ZIKV is lim-
ited and the true phenotype of disease in ZIKV endemic areas in Africa needs to be investi-
gated in detail.
ZIKV is not the first arbovirus to show sudden emergence and global spread. In fact,
ZIKV has followed a trajectory displayed earlier by chikungunya virus, which in the course
of evolution acquired a small number of mutations allowing it to use additional species of
Aedes mosquitos for transmission [42]. Interestingly from the time of ZIKV discovery to its
emergence and spread, several changes have been found spread across its genome [6, 7].
These changes may affect the rate of ZIKV replication, expand its host range, alter the ZIKV
tissue tropism, and/or enhance the ability of ZIKV to induce, antagonize or escape the host
immune response. Our studies show ZIKV strain specific differences in inducing disease in
mice, which are associated with differential activation of proinflammatory cytokines, empha-
sizing the possibility that different ZIKV strains might also display phenotypic differences in
humans. If so, these differences might have contributed to the ZIKV global spread and to
changes in the spectrum of disease in humans during the recent years. It will be critical to
employ reverse genetics tools to systematically address the role of specific genetic changes in
ZIKV strains in their pathogenesis and host range. The Stat2-/- mouse model described here
could be a useful tool to evaluate the pathogenesis of recombinant ZIKV carrying different
combinations of these genetic changes.
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Materials and methods
ZIKV strains and mouse genotypes
The following ZIKV strains were used in this study: Uganda 1947 (Strain MR 766; GenBank
HQ234498.1), Puerto Rico 2015 (Strain PRVABC59; GenBank KU501215.1), Cambodia
2010 (Strain FSS13025; GenBank: JN860885.1), Malaysia 1966 (Strain P6-740; GenBank
HQ234499.1) and Senegal 1984 (Strain DAKAR 41519; GenBank HQ234501). The Uganda
strain was obtained from American type culture collection (ATCC). All virus stocks were
grown in Vero cells and quantified by plaque assay. A summary of isolation history of all
ZIKV strains and related references is provided in S1 Table. Malaysia, Cambodia and Sene-
gal ZIKV strains were obtained from Dr. Robert B. Tesh, The World Reference Center for
Emerging Viruses and Arboviruses (“WRCEVA”), through the University of Texas Medical
Branch at Galveston. Puerto Rico ZIKV strain was provided by Barbara W. Johnson. Stat2-/-
C57BL/6 mice were kindly provided by Dr. Christian Schindler. Ifnar1-/- C57BL/6 mice defi-
cient in IFN α/β receptor -/- were kindly provided by Dr. Thomas Moran. WT C57BL/6
mice were obtained from Jackson Laboratories.
Virus stock growth and quantification
Virus stocks were grown in Vero (African green monkey kidney) cells and in some cases pas-
saged in C6/36 (Aedes albopictus cells), which were obtained from ATCC. Virus titers of the
stocks were measured by plaque formation assay on Vero cells. Specifically, 100 μl of 10 fold
virus stock serial dilution was incubated for 2 hour on Vero cell monolayer in 12 well plate for-
mat. Finally cells were overlaid with 1 ml DMEM (Invitrogen) supplemented with 0.8% methyl
cellulose, 2% FBS, and 50 μg/ml penicillin and streptomycin. Cells were incubated for 5 days at
37˚C, fixed with 4% PFA, and stained with crystal violet for plaque visualization.
ZIKV infection and clinical evaluation of mice
Prior to ZIKV inoculation, mice were anesthetized by intraperitoneal injection of a mixture of
ketamine (100 μg per gram of body weight) and xylazine (5 μg per gram). Afterwards, 1,000
PFUs of the indicated ZIKV strain were injected subcutaneously in the mouse footpad in 25 μl
of phosphate-buffered saline (PBS). Mice were monitored daily for weight loss and clinical
signs. Examination included appearance, posture, motility, hind and front limb paralysis. Ani-
mals that showed more than 25% weight loss or complete paralysis were humanely euthanized.
ZIKV quantification by qPCR
Infected mice were euthanized by CO2 asphyxiation and organs were harvested aseptically.
Tissue homogenates were prepared in PBS supplemented with 0.3% BSA, using metal beads
and a FastPrep24 system (MP Biomedicals). ZIKV RNA quantification was conducted as pre-
viously described. Briefly, total RNA was isolated from 200 μl tissue homogenate using RNeasy
tissue Kit (Qiagen) or 50 μl plasma using QIAamp viral RNA kit (Qiagen). In total, 10ng of
RNA or 5 μl of plasma RNA was used with ZIKV-specific primers (50-TTGGTCATGATACTG
CTGATTGC-30 and 50-CCYTCCACRAAGTCYCTATTGC-30) and probe (50-6FAM-CGGCA
TACAGYATCAGGTGCATWGGAG-MGBNFQ-30) (ThermoFisher) and the LightCycler 480
Master Hydrolysis Probes kit (Roche Applied Science, Indianapolis, MD) using the LightCy-
cler 480 II Real Time PCR System (Roche Applied Science). Sequence of the primers and
probe targeting ZIKV have been modified from previously published sequences [43] and
designed against genomic regions conserved in different ZIKV strains used in the study. RNA
quantification was achieved by fitting to an in vitro transcribed RNA standard.
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Gene expression quantification by qRT-PCR
Total RNA was isolated from cells using Trizol reagent (Invitrogen). Reverse transcription was
performed with the high-capacity cDNA reverse transcription kit (Applied Biosystems). qPCR
was done in duplicates using SYBR green I master mix (Roche) in a Roche Light Cycler 480.
Relative mRNA values were calculated using ΔΔCt method with 18s RNA as an internal con-
trol, and shown as fold change by normalizing to mock control. The sequences of primers
used in the study are listed in S3 Table.
Cytokine and chemokine protein quantification
Protein levels of cytokines/chemokines in clarified tissue homogenates were evaluated using a
multiplex bead array assay. All antibodies and cytokine standards were purchased as antibody
pairs from R&D Systems or PeproTech. Individual magnetic bead regions (Luminex) were
coupled to cytokine-specific capture antibodies according to the manufacturer’s recommenda-
tions and as previously described [44]. Conjugated beads were washed and kept at 4˚C until
use. Biotinylated polyclonal antibodies were used at twice the concentrations recommended
for a classical ELISA according to the manufacturer. All assay procedures were performed in
assay buffer containing PBS supplemented with 1% normal mouse serum (Invitrogen), 1%
normal goat serum (Invitrogen), and 20 mM Tris-HCl (pH 7.4). The assays were performed
using 1,500 beads per set of each of cytokines measured per well in a total volume of 50 μl. The
plates were read on a Luminex MAGPIX platform. For each bead set, >50 beads were col-
lected. The median fluorescence intensity of these beads was recorded and used for analysis
with the Milliplex software using a 5P regression algorithm.
Phylogenetic analysis
To prepare a phylogenetic tree presenting the global diversity of the Zika virus strains, we
downloaded all the available complete genomes from the Virus Pathogen Resource database
(www.viprbrc.org/). From these genomes we manually selected a subset of sequences represen-
tative of the complete diversity to build the phylogenetic tree. The final selection contained
one viral genome from each country and year available, including the 5 strains used in this
study. Viral sequences were aligned using the MUSCLE algorithm in MEGA7 (version 7.0.20)
and a neighbor joining tree was built using the program Geneious (version 9.1.5). The tree was
visualized with the program FigTree and rooted at the midpoint.
Statistical analysis
All data were analyzed with GraphPad Prism software (Graphpad Software, Inc). For survival
analysis, Kaplan-Meier survival curves were analyzed by the log-rank test. An unpaired Stu-
dent’s t-test was used to determine significant differences in viral RNA levels. Values were con-
sidered statistically significant when p<0.05, p<0.01, p<0.001, and p<0.0001,
nsp>o.o5 (not significant). Data are given as mean ± SD or mean ± SEM as indicated; ‘n’ refers
to the sample size.
Ethics statement
This study was carried out in strict accordance with recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health. All mouse proce-
dures were approved by Institutional Animal Care and Use Committee (IACUC) of the
Icahn School of Medicine at Mount Sinai and performed in accordance with the IACUC
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guidelines (Protocol # IACUC-2016-0026: “Developing animal models of flavivirus
pathogenesis”).
Supporting information
S1 Fig. Kinetic analysis of ZIKV replication in Stat2-/- mice. Three groups of five to six week
old female Stat2-/- B6 mice (n = 5) were injected with 1,000 PFU of ZIKV strain MR 766 by the
subcutaneous route in the footpad. Indicated organs were harvested on indicated days (D2 = 2
days post infection, D4 = 4 days post infection, D6 = 6 days post infection) and ZIKV RNA lev-
els were measured by qRT PCR as described in methods. D6 group is the same set of animals
used to measure ZIKV RNA in Fig 1D. Error bars represent mean ±standard deviation (SD).
Y axis starts at the limit of detection of the assay.
(TIF)
S2 Fig. Comparison of clinical signs induced by African and Asian ZIKV strains in
Ifnar1-/- mice. (A, B) Clinical signs of ZIKV infection were monitored every day in the group
of animals used for survival analysis in Fig 3B (n = 5). Clinical signs are abbreviated as HB
(hunched back, reduced motility), HL1 (one hind limb paralysis), HL2 (both hind limbs para-
lyzed), FL (one or both front limbs paralyzed), Endpoint (loss of 25% of initial body weight or
dead). The percentage of each group of mice displaying the indicated signs is shown. (A) Data
represent mice infected with African lineage strains observed between day 3 to day 7 post
infection for Uganda and day 4 to day 8 post infection for Senegal strains. (B) Data represent
Asian lineage strains between day 8 to day 12 post infection.
(TIF)
S3 Fig. Comparison of ZIKV pathogenesis in female Stat2-/- mice. (A) Six week old female
Stat2-/- C57BL/6 mice (n = 3 for mock; n = 4 other groups) were injected with 1,000 PFU of
the indicated ZIKV strain by the subcutaneous route in the footpad. Mice were weighed daily
and weights are expressed as percentage of body weight prior to infection. Results shown are
the mean ± SEM. Data are censored at 6 days after infection, as mice were euthanized for brain
harvesting. (B) ZIKV RNA levels were measured in the brain homogenates by qRT PCR as
described in methods. Error bars represent mean ±standard deviation (SD). ZIKV strains are
abbreviated as SN (Senegal), CB (Cambodia) and PR (Puerto Rico). (C) Mouse cytokine
mRNA expression in brain was measured by qRT PCR as described in the methods section.
Fold change of the gene expression over the mock was calculated and plotted on the graphs.
Data are presented as log 2 fold increase over mock controls mean ±standard deviation (SD).
(TIF)
S1 File. Amino acid sequence alignment of the ZIKV strains used in the study.
(DOCX)
S1 Table. Source host, isolation and passage history of ZIKV strains used in the study.
AP61 = Aedes pseudoscutellaris cells; BHK = baby hamster kidney epithelial cells; C6/36 =
Aedes albopictus cells; SM = suckling mouse; Vero = African green monkey kidney cells.
(XLSX)
S2 Table. List of GenBank accession numbers of ZIKV reference sequences used for phylo-
genetic analysis.
(DOCX)
S3 Table. Sequences of qRT PCR primers used in the study.
(XLSX)
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